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Human serum contains an inactive proteolyfic enzyme, plasminogen, which 
may be converted to its active form, plasmin,  either  spontaneously or by the 
addition  of  various  agents.  Plasmin  digests  fibrinogen,  fibrin,  prothrombin 
(1), and accelerator globulin (2) at or near neutral pH, but little or nothing is 
known about its activity on other serum proteins. 
Human  serum  also  contains  a  complex  of  substances,  known  collectively 
as complement, of which four components have been recognized (3,  4).  Com- 
plement plays a  significant role in certain immune reactions. 
Streptokinase,  a  principle found in filtrates of cultures of hemolytic strepto- 
cocci, converts plasminogen  to plasmin  (5-7).  We have found that  the addi- 
tion  of  streptokinase  to  human  serum  also  inactivates  complement.  This 
suggested  that  plasmin  digested  components  of  complement.  It  was  further 
noted  that  complement  components  are  destroyed  by  chloroform-activated 
plasmin.  These observations and  their  biological implications are reported  in 
this paper. 
Nomenclature 
Complement is designated  C' and its four recognized components  are indicated  by the 
symbols C'I, C'2, C'3, and C'4 (8). Serum fractions employed as reagents for the titration of 
the components of C' are designated R1, R2, R3, and R4 (9). R1, for the titration of C'I, 
consists of the proteins soluble at pH 5.4 and ionic strength 0.02 at 0  ° (10). R2, for the titra- 
tion of C'2, contains the proteins insoluble at pH 5.4 and ionic strength  0.02 at 0  ° (10). R3, 
the test reagent for C'3, is prepared  by treatment of C' with zymosan (10, 11). R4, for the 
titration  of C'4, is prepared by the addition of hydrazine to C' (10, 12). Detailed procedures 
for the preparation  and characterization  of these reagents have been published (4, 9, 10, 13). 
The terms  plasmin, plasma proleolytic enzyme, and  plasma protease will be used  inter- 
changeably  to designate the substance  or substances in plasma or serum which can digest 
fibrinogen, fibrin, and certain  other proteins  in v/fro at or near neutral  pH. This enzyme, 
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which has also been called fibrinolysin (14), is usually present in plasma or serum as an inac- 
tive precursor, sometimes designated plasminog~a. The filterable principle of cultures of beta- 
hemolytic streptococci which activates the precursor will be called streptokinase (SK)  (15). 
The clot lysis time is the length of time required for a  visible clot to disappear. In all experi- 
ments, the clot lysis time was measured from the time that the reagents were mixed, rather 
than from the time that clotting took place. This was a  matter of convenience, because the 
clotting time was usually short compared with the clot lysis time. 
Materials 
Complonent.--Human blood from healthy donors was chilled shortly after being drawn. 
The serum was separated within 15 hours and centrifuged clear of red cells at 4000 Ra,.x~. 
at 1  ° in a refrigerated centrifuge. The clear serum was maintained at 1  ° until needed and any 
unused portion discarded after 24 hours. R1, R2, R3, and R4 were diluted with 0.15 ~r NaCI 
to 1.5 times the original serum volume, adjusted to pH 7.0 4- 0.2, and maintained at  1  ° until 
needed. 
Sensitized Sheep Cdls.--The red cells from fresh sheep blood collected in Alsever's solution 
(16) were washed 3  times with barbital buffer (17) containing 0.0015 M CaC12 and 0.0005 
~t MgC12 and then suspended to a 1.25 per cent suspension in buffer containing 4 units per ml. 
of rabbit hemolysin. 
Streptokinase.--"Varidase,  ''1 a lyophilized preparation of streptokinase, was dissolved in 
distilled water or barbital buffer. This preparation contained streptococcal desoxyribonuclease 
as well as streptokinase. 
Trypsin and Pancreatic Desoxyribonuclease.--Each  once recrystalized, and obtained from 
Worthington  Biochemical  Company. 
Plasmin.--A crude solution of human plasmin, activated by chloroform, was  prepared 
by a  method previously described (18). Chloroform-activated bovine plasmin,  s prepared by 
the method of Loomis, George, and Ryder (14)  was also tested. The preparation used con- 
tained 0.82 Loomis unit per rag. 
Bovine  TkrombinS.--The  thrombin was  dissolved in  buffer to  a  concentration of  1000 
National Institutes of Health (N.I.H.)  units (19) per ml., stored at --20  °, and diluted to 10 
N.I.H.  units per  ml.  with barbital buffer when needed. 
Bovine  F~brinogen.~--Fibrinogen, prepared by the method of Ware,  Guest, and  Seegers 
(20), was dissolved in barbital buffer and the undissolved residue was separated by filtration 
through Whatman No. 1 falter paper. In all experiments with the fibrinolytic system, 100 nag. 
portions of dried fibrinogen, which contained sodium chloride in a ratio of 3.1 gm. of protein 
to 0.9 gm. of salt, were dissolved in 2.6 ml. of water and 17.4 ml. of barbital buffer. Assay of 
the filtrate demonstrated approximately 300 mg. of coagulable protein per 100 ml. of solution. 
Barbital Buffer.--Buffer for use in the fibrinolyffc system consisted of 0.025 M barbital and 
0.125  ~  sodium  chloride  at  pH  7.5. 
All other reagents were the best grade obtainable. Double distilled water was employed 
throughout.  All glassware was  cleaned with sodium  dichromate-sulfuric acid  solution and 
washed  in distilled water  until free of  all traces of cleaning solution. International PR-1 
refrigerated  centrifuges were  used  for  centrifugation.  Constant  temperature  water  baths, 
accurate to -4- 0.5  ° , were employed for incubation. Hydrogen ion determinations were made 
with  the  Cambridge  research  model pH  meter. 
t Kindly supplied by F.  Ablondi of Ledefle Laboratories Division, American Cyanamid 
Company. 
2 Kindly supplied by Dr. E. C. Loomis of Parke, Davis and Co. 
s Kindly supplied by Dr. E. C. Loomis of Parke, Davis and Co. 
4 Kindly  supplied  by  Dr.  Walter  Seegers. L. PILLEMER,  O. D. RATNOFF,  L. BLUM, AND  I. H. LEPOW  ~75 
Methods 
Titration of C' and Its Components  (4, 9, 10, 13).--All titrations were carried out at the 50 
or 100 per cent hemolytic end-points, or both. A unit of complement is defined here as the 
smallest amount of complement which will cause complete hemolysis of 1 ml. of a  1.25 per 
cent suspension of sensitized cells in a final volume of 1.5 ml. after 30 minutes at 37  °. A 50 
per cent unit  represents the  smallest amount  of complement, or mixture of complement 
components and complement reagents, necessary to produce lysis of 50 per cent of the cells 
in this system. 
A rough determination was made of the presence or absence of a component of complement 
in specific reagents and in serum after treatment with streptokinase or other agents. Two 100 
per cent units of complement inactivated by different methods were added to an equal amount 
of test reagents. 1 ml. of sensitized cells was added and the volume brought up to 1.5 ml. with 
buffer. The mixture was incubated at 37  ° for 30 minutes and finally centrifuged at  1500 
R.e.M. for 5  minutes. The clear hemoglobin supernatants were compared with a  series of 
standard hemoglobin solutions and the degree of hemolysis was expressed as percentage of 
complete hemolysis. 
The estimation of the actual titer of individual components was carried out with slight 
modification as described by Bier et al.  (9) and by Kabat and Mayer (13) using a 50 per cent 
hemolytic end-point. For example, 2  to 3  units of test reagents were added to 0.2  ml. of 
varying dilutions of an inactivated C'; 1 ml. of sensitized cells was added, and the mixtures 
were incubated at 37 ° for 30 minutes. They were then centrifuged at 1500 R.P.M. for 5 min- 
utes and the amount of the inactivated C' which gave 50 per cent hemolysis in the presence 
of the test reagents was considered a unit. The dilution of sample multiplied by 5 gave the 
total number of component units per milliliter of sample. Untreated C  t was tested simul- 
taneously and the results were expressed either in units or as per cent inactivation of each 
component compared  to  the  untreated  serum. 
General  Methods for  Testing the Inactivation  of C  r by Streptokinase, Plasmin,  etc.--To x 
ml. of human serum of known C' activity, y ml. of streptokinase containing a specified num- 
ber of units, or other agents, was added with stirring at the desired temperature, ionic strength, 
hydrogen ion concentration, and serum dilution. The mixtures were then incubated at the 
desired temperature for 1 hour and immediately tested for C ~  activity, C t component activity, 
or both. In some experiments, samples were stored at 0  ° before testing because it was found 
that streptokinase did not destroy C' in a few hours at this temperature. The ionic strength 
did not exceed 0.15 except in experiments in Tables VI, VII, and VIII. 
The spontaneous  proteolytic  activity  of serum was assayed in the following manner. The 
sample to be tested was diluted serially 256-fold  with buffer. 0.3  ml. of each dilution was 
mixed with 0.3 ml. of bovine fibrinogen and the mixture was then clotted by the addition of 
0.1  ml. of bovine thrombin. A  drop of toluol was added to each tube and the tubes were 
stoppered, incubated at 37 °, and observed frequently for evidence of fibrinolysis.  Normally no 
fibrinolysis is observed by  this technique within 48  hours. 
The inhibitory activity of serum was tested against plasmin. The substance to be tested was 
diluted serially 256-fold with buffer. 0.3 ml. of each dilution was mixed with 0.3 ml. of bovine 
plasmin. The mixtures were incubated at room temperature for 10 minutes and then placed 
in an ice bath. 0.1  mi. of bovine thrombin and 0.3  ml. of bovine fibrinogen were added in 
succession. The mixtures were then incubated at 37  ° and observed for fibrinolysis.  In each ex- 
periment the rate of fibrinolysis was compared with the rate of fibrinolysis by plasmin in the 
absence of the substance to be tested. In most experiments, the concentration of enzyme, 
after all dilutions, was 0.75 Loomis unit per ml. 
The total amount of plasmlnogen  which was available for activation by streptokinase cannot 
be estimated satisfactorily because serum contains substances which interfere with the activa- 
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of the amount of plasminogen  available were made in the following way. The serum was 
diluted to one-fourth its original concentration with buffer. 0.3 ml. of the diluted serum was 
mixed with 0.3 ml. of streptokinase solution which had been  diluted serially with buffer. 
The mixtures were allowed to stand at room temperature for 10 minutes.  Then 0.1 ml. of 
bovine thrombin and 0.3 ml. of bovine fibrinogen were added to each tube. The clot lysis 
time of the mixtures was determined at 37  °. The concentration of streptokinase in the tube 
with the shortest clot lysis time was considered optimal. 1 ml. of the serum to be tested, diluted 
with buffer to one-fourth its original concentration, was then mixed with an equal volume of 
streptokinase solution  of optimal concentration and allowed to stand at room temperature 
for 10 minutes.  The mixture was then diluted serially 128-fold with buffer. 0.6 ml. of each 
dilution was then mixed with 0.1 ml. of bovine thrombin and 0.3 ml. of bovine fibrinogen. 
The rate of clot lysis was then observed at 37 ° and compared in the various samples tested. 
RESULTS 
1.  The Effect of Streptokinase  (SK)  on C'  of Various Species.--Fresh  pooled 
serums from human  adult, human  infant  (age 2  to 3  months),  monkey, rab- 
TABLE I 
The Effect on C' of the Addition of Streptokinase to Serums of Various Animals 
Serum  SK units/ml, serum  required  to inactivate  C' 
Human adult 
Human infant 
Monkey 
Rabbit 
Dog 
Guinea pig 
75-150 
2000-5000 
>50,000 (ca. 50 per cent inactivation at 20,000) 
>50,000 (ca. 50 per cent inactivation at 50,000) 
>50,000* 
>50,000* 
* Highest concentration tested was 50,000 per ml. which only slightly reduced the C' titer. 
bit, dog, and guinea pig were incubated with varying amounts of streptokinase 
at 37 °  for  1 hour.  It will be seen in Table I  that small amounts of SK inac- 
tivated human  adult C'.  10  to 50  times more SK was required to inactivate 
infant C' than adult C'.  C' from other animal serums was only slightly or not 
at all inactivated by enormous doses of SK. 
Mixtures of human, monkey, and guinea pig C' were treated with 500 units 
of  SK  and  the  C'  titer  determined.  These  experiments  are  summarized  in 
Table II which shows that the addition of SK to a mixture of an equal part of 
human serum and either monkey or guinea pig serum resulted in the inactiva- 
tion of both the monkey or guinea pig C' along with the human  C'. Monkey 
alone, guinea pig alone, or mixtures of these two serums were not inactivated 
by SK. These results eliminated the possibility of a  direct action of SK on C' 
and  indicated that  the  human  plasmin  activated by  SK had  the  ability to 
destroy C' of guinea pig and monkey serum. However, the experiment did not 
differentiate between  the possibilities that either monkey and  guinea pig se- 
rums  were  low  in plasminogen or  that  the  SK was  specific for human  plas- 
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2.  The Effect of Desoxyribonuclease.--"Varidase,"  which is a  purified prepa- 
ration  of  streptokinase,  contains  varying  amounts  of  desoxyribonuclease. 
Streptokinase has not been prepared free of this enzyme and it seemed neces- 
sary  to  determine  the  effect  of  desoxyribonuclease  on  C'.  Crystalline pan- 
creatic desexyribonuclease, in amounts varying from 0.1 to 10 nag., was added 
to 1 ml. of human serum, incubated for 1 hour at 37 °, and then tested for C'. 
TABLE II 
The Effect on C  t of the Addition  of Streptokinase  to Mixtures of Monkey,  Guinea Pig, and 
Human Serum 
Human serum  Monkey serum  Guinea pig serum  SK  C' activity 
ral.  units  ml. 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
rat. 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
500 
500 
500 
500 
500 
500 
0 
0 
0 
0 
0 
kemolytic  units/rat. 
0 
0 
0 
92 
2O 
163 
22 
95 
25 
20 
163 
All mixtures made up to a final volume of 1.5 ml. with 0.9 per cent saline. 
TABLE III 
The Effect on C' of the Addition  of Streptokinase to Human Serum at 1  ° and 37  ° 
Human serum  SK  Conditions  C' activity 
rat.  units 
(2t)2  2000  1 hr. at 37  °  0 
(]3)2  2000  24 hrs. at 1  °  100 
(C)  Serum B, reincubated for 1 hr. at 37  °  0 
No  inactivation of  C ~ occurred  and  it appeared  that  pancreatic desoxyribo- 
nuclease did not destroy C p. 
3.  The Possible Role of Complement Fixation.--It  is well known  that human 
serum  may  contain varying amounts  of antibodies to  streptokinase because 
of previous streptococcal infections.  It is also well known  that  antigen-anti- 
body aggregates will  inactivate  C'.  "Fixation" of  C'  to  immune  aggregates 
occurs at  1  ° as well as at 37 °  (21,  22). If SK failed to inactivate C' at  1  ° but 
did inactivate it at 37 ° ,  this would be additional evidence that  "fixation" of 
C' was not involved. The results of such an experiment are given in Table III 
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to  inactivate  C' at  1  °  in 24 hours,  while such amounts destroyed  C' readily 
at 37 ° in 1 hour. Reincubation of the serum which had been treated with SK 
at 1  ° for an additional hour at 37 ° inactivated Cq These results indicate that 
SK  destroyed  C'  indirectly  by  converting  plasminogen  to  plasmin  which 
in turn acted upon C'. 
4.  The Effect of Temperature.--The  effect of  temperature  is  portrayed  in 
Fig.  1 which  shows the effect on human  C p of the concentration of SK as a 
function  of temperature and  time.  It will be observed that  the inactivation 
of C t was dependent both upon temperature and SK concentration, proceeding 
faster at higher  temperatures and higher  concentrations  of SK. At tempera- 
....... O:C.  o  1600  SK  Units 
-.---12  C.  •  400  SK  Units 
----24°C.  =~  I00  SK  Units 
" 37*C. 
Ioo 
°  .....  1 
"~  20  .......  2......- 
60  120  240  1440 
Time  in  Minutes 
FIC.  1. The effect of temperature on the inactivation of C ~ by streptokinase. 
tures above 12  ° the same degree of inactivation of C t could be achieved either 
by incubating at higher temperatures with a  given amount of SK or at lower 
temperatures with larger amounts of SK. The degree of inactivation per unit 
time appeared to be more sensitive to temperature than to SK concentration. 
5. The Influence of Hydrogen Ion Concentration.--Aliquots  of a pool of fresh 
human  serum  were  adjusted  to  various  hydrogen  ion  concentrations  with 
HCI or NaOH. Untreated serums and mixtures of these serums with strepto- 
kinase were incubated for 1 hour at 37 ° and then tested for C' activity. The re- 
sults  of  this  experiment are  summarized in Table IV which  shows  that  (1) 
hydrogen ion concentrations greater than pH 7.0 inhibited the action of SK, 
and (2)  SK operated optimally at neutral or alkaline pH. These results, with 
the exception of the increased inactivation of C' by SK at pH 8.9,  are similar L.  PILLEMER,  O.  D.  RATNOFF,  L.  BLUM,  AND  I.  H.  LEPOW  579 
to those reported earlier  (23)  for the effect of pH on the digestion of  casein 
by ptasmin. 
Table V further shows the effect of pH on the inactivation of the compo- 
nents of human C' by SK. It will be observed that no inactivation of C'1 and 
only slight inactivation of C'3 occurred at pH 5.5  and that fully 80 per cent 
of C'2 and  C'4 activity was destroyed. Upon increasing the alkalinity of the 
mixtures, C'1, C'2, and C'4 were progressively inactivated while C'3 maintained 
TABLE IV 
The Influence of  ,H on the InactivaZion of C' by Streptokinase-Adivated Plasmin 
Serum  II  Untreated serum  q- 100 units SK/ml.iSerum -k 500 units SK/ml. 
Final pH 
Original C' activity remaining 
5.5 
6.6 
8.0 
8.5 
8.9 
95 
100 
100 
100 
95 
per cerd 
80 
6O 
2O 
35 
<5 
3O 
0 
0 
0 
0 
Serum and reagents adjusted to desired final pH with HC1 or NaOH. Mixture of serum and 
streptokinase, and serum alone incubated for 1 hour at 37  ° and then tested for C' activity. 
TABLE V 
The Influence  of pH  on  tt~ Inadivalion  of lhe Components of C' by 
Slreptokinaze-Activate.d Plasmin 
Serum 4- 15o SK 
unlts/ml,  Inactivation 
pH  C'I  C'2  C'3  &4 
5.5 
6.8 
7.8 
8.5 
per ¢,~t 
0 
75 
85 
95 
l~r c.¢n/ 
80 
>95 
>95 
100 
pe¢ cerd 
2O 
50 
50 
5O 
per c~ 
80 
>95 
>95 
100 
50 per cent of its activity even at pH 8.5. These results compare favorably with 
those shown in  Table  IV on the  effect of pH on C' titer  and  indicate  that 
the  immediate  inactivation of  C ~ by plasmin  was  due  to  the  destruction  of 
C'2 and C'4. 
6.  The Effect  of Ionic  Strength.--Mixtures  of different amounts of SK and 
aliquots of human serum  adjusted  to  the desired  final ionic strength  with  2 
NaC1 were incubated at 37  ° for 1 hour and tested for C' activity. It will be 
seen in Table VI that  the ionic strength of the medium had a  profound in- 
fluence on the action of SK. At ionic strengths over 0.15  (isotonic), the inac- 580  INACTIVATION  0]~ COMPLEMENT  AND  CO~KPONENTS 
tivation of C' by SK was inhibited, becoming most marked at 0.3 but recog- 
nizable at  0.2.  Increasing  the  concentration  of  SK  overcame  this  inhibition 
to some extent but did not entirely abolish it. 
TABLE VI 
The Influence of Ionic Strength on the Inactivation  of C'  by Streptokinase 
Ionic strength*  SK/ml. undiluted serum  C' activity remslning 
0.075~ 
0.15 
0.20 
0.25 
0.3 
0.075t 
0.15 
0.20 
0.25 
0.30 
0.0751: 
0.15 
0.3 
0.6 
uni|s 
IO0 
IO0 
IO0 
100 
100 
200 
200 
200 
200 
200 
i000 
i000 
I000 
1000 
5 
5 
45 
8O 
100 
0 
0 
5 
40 
80 
0 
0 
25 
70 
* Human serum adjusted to desired final ienic strength with 2 ax NaCI and made up to a 
final dilution of 1:2 with H20. Mixtures incubated for 1 hour at 37  ° and then tested for 
C' activity. 
Diluted with an equal part of water. 
TABLE VII 
The Influence of Ionic, Strength  on the Activation  of Plasmin by Streptokinase* 
I 
Ionic strength .........................  ]  0.10 
............  I  Clot lysis time, rain  .............  ]  2  -•t 
0,25  O.3O 
9  11 
* Clot lysis time of a mixture of 0.1 ml. thrombin, 0.1 ml. streptokinase (312 units per 
ml.), 0.3 ml. sodium chloride or water, 0.2 ml. fresh serum, and 0.3 ml. bovine fibrinogen. 
The  effect of hypertordc solutions may have been due  to kuhibition of the 
activation of plasminogen by SK, or to inhibition of the active enzyme, plas- 
rain.  Preliminary experiments make  it seem  likely that  hypertonic solutions 
interfere  with  the  activation  of  plasminogen  by  SK.  Increasing  the  ionic 
strength inhibited fibrinolysis by mixtures of serum and suboptimal amounts 
of SK  (Table VII). This inhibitory effect was  noted  even  though  increasing 
the ionic strength increased the rate of fibrinolysis by active bovine protease L.  PILLEMER,  O.  D.  RATNOFF,  L.  BLUM,  AND  I.  H.  LEPOW  581 
(Table  VIII).  One  may  conclude  tentatively  that  the  inhibitory  effect  of 
ionic  strength  was  on  the  activation process.  In any event,  caution  should 
be observed in maintaining precise  control  of the salt concentration  in  test- 
ing SK. It would appear safer to work in hypotonic than in hypertonic media. 
It is possible that some of the many reported activators or inhibitors of plas- 
min may have exhibited their actions by virtue of a non-specific ionic strength 
effect. 
TABLE VIII 
The Influence of Ionic Strength on the Activity of Bovine Plasrain* 
Ionic strength .........................  0.10  0.15  0.20 
Clot lysis time, rain  .............  19~  11  9 
 22_%   .3o 
* Clot lysis time of a mixture of 0.1 ml. thrombin, 0.3 ml. bovine plasmin (2.5 Loomis 
units per ml.), 0.3 ml. sodium chloride in varying concentrations, and 0.3 ml. bovine fibrin- 
ogen. 
:~ Poor end-point. 
TABLE IX 
The Inactivation  of the Components of C' by Streptokinase-Aaivated Plasmin 
SK units/ml, of serum 
0 
100 
300 
2000 
Cq 
~er Ceftt 
0 
15 
67 
75 
Ins cfivation of complement  component 
C"2  Ct3 
#er <:e~  l~  c,,ml, 
0  0 
80  5 
93  25 
96  25 
C~4 
~er ce~ 
0 
94 
100 
100 
It is  interesting  that  hypertonic  salt  solution  also  inhibits  the  "fixation" 
of the  components of C ~ to immune aggregates (22)  and  the inactivation  of 
C'3 by zymosan (24). 
7.  The Inactivation  of C' Components.--In  the preceding sections, the effect 
of SK-activated plasmin was  observed mainly on  C ~ activity.  Studies  were 
next undertaken to discover the effect of SK-activated plasmin on the individ- 
ual components of C ~. 
Varying amounts of SK were added  to human serum and the per cent in- 
activation of each C ~ component measured. The results are given in Table IX 
which  shows that addition  of small amounts of SK to  serum  (100  units/ml. 
of serum) destroyed mainly C~4 and C'2 but had little effect on Cq and C~3. 
The  addition  of increasing  concentrations  of  SK  (300  to  2000  units/ml,  of 
serum)  caused destruction also of Cq,  with  Cr3  remaining most resistant  to 
inactivation.  The use of similar amounts  of SK in  the  fibrinolytic assay re- 582  INACTIVATION OF COMPLEMENT  AND COMPONENTS 
vealed that 100 SK units/ml, of serum failed to digest a fibrin clot completely 
in 24 hours, while 400 and 1600 units caused rapid clot lysis (Table X).  It  is 
of interest  to note that  C'4 is also rapidly and almost  completely removed 
by immune aggregates (22)  and  is  immediately involved in  immune fixation 
and lysis. It is also of interest that C'3 which is poorly, if at all, fixed by im- 
mune systems (22), is most resistant to inactivation by plasmin. 
8.  The Inactivation  of C' Components  by the Addition of SK to R1, R2, R3, 
and R4.--Experiments were designed to test the effect of the addition of SK 
to fractions of C' lacking one or more components and fractions rich or poor 
in plasminogen or its inhibitors. The results of these experiments are given in 
Table XI which shows that:-- 
R2, the fraction of serum insoluble at pH 5.4 and ionic strength 0.02, which 
is  rich in plasminogen and poor in  its inhibitors  (25,  26),  required only 16 
units of SK to destroy Cq, C~3, and C~4 while 25 to 100 times as much SK was 
required to destroy completely these components in whole serum. 
TABLE X 
The  Activation  of  Plasminogen  by  SIreptokinase* 
Final .....  concentration  of SK units/ml .......  O, 
Clot lysis time, rain  .............. ]  > 1440 
i00 
144o~ 
1600 
* Clot lysis time of a mixture of 1 ml. of human serum, 0.05 ml. of streptokinase  in varying 
concentrations, 0.05 ml. of bovine thrombin, and 0.4 ml. of bovine fibrinogen. 
Partial lysis only. 
R1, the fraction of serum soluble at pH 5.4 and ionic strength 0.02, which is 
rich in protease inhibitors but low in plasminogen (25,  26), required amounts 
of  SK  similar  to  those  required  for  whole  serum  to  inactivate  the  small 
amounts  of C'3 and C'4 present in R1, while C'2 appeared to be unaffected 
by large doses of SK.  Apparently,  the small  amounts of available activated 
plasmin were not able to destroy C'2  in the presence of a  large excess of inhi- 
bitor. The total C'3 and C'4 content in this R1 was about 25 per cent of that 
present in untreated  serum  and would, of course, be  inactivated by smaller 
amounts of plasmin than those required for whole serum. 
The effect of SK on the components of C' present in fractions R3 and R4 
was  almost  identical with its effect on the components in untreated  serum. 
R3 and R4 are serums which have been treated with zymosan and hydrazine 
respectively. Fractions R3 and R4 contained the same amount of plasminogen 
as untreated serum. Furthermore, treatment of serum with zymosan or hydra- 
zine did not result in abnormal spontaneous activation of plasminogen of the 
serum as measured by incubation at 37  ° for 48 hours in the fibrinolytic sys- 
tem.  However, the inhibitory activity of serum against  bovine plasmin  was L.  PILLEMER,  O.  D.  RATNOFF~ L.  BLUM, AND I.  H.  LEPOW  583 
decreased by incubation at 37 °  for 1 hour with one-fifth its volume of 0.16 ~r 
hydrazine  of  pH  7.8  (Table XII).  This  observation  implies that  hydrazine 
either destroys inhibitors of plasmin along with C'4, or that C'4 itself may be 
an inhibitor of plasmin. Zymosan was without effect on the protease inhibitory 
TABLE XI 
Tkeln~tivat~nbySK-Ac~at~ Plasmin ~Components ~C'inFrutions ~C' 
Fraction* 
R1 
R1 
R1 
R1 
R2 
R2 
R2 
R2 
R3 
R3 
R3 
R3 
R4 
R4 
R4 
R4 
Serum 
Serum 
Serun~_ 
Serum 
SK/ml. of fraction 
u~s 
2,000 
4OO 
80 
16 
2,000 
400 
80 
16 
-2,000 
4OO 
80 
16 
2,000 
400 
80 
16 
2,000 
400 
80 
16 
Inactivation of each component~ 
ci1 
pl 
Ct2 
per ¢¢n/. 
15 
0 
0 
0 
100 
80 
30 
20 
100 
80 
30 
20 
C'3 
pet c~rd 
50 
50 
2O 
0 
100 
95 
9O 
90 
100 
95 
60 
30 
95  50 
90  50 
80  5 
20  0 
C'4 
per ce~ 
100 
9O 
5O 
30 
IO0 
100 
IO0 
100 
100 
100 
100 
30 
100 
100 
95 
30 
* R1  =  deficient in C'I; R2  -- deficient in C'2; R3  =  deficient in C'3; R4 =  deficient 
in C'4. 
:~ Per cent inactivation of components  originally present in each fraction. 
activity of serum. It should be pointed out that there is slight inactivation of 
all components of C' in the preparation of these reagents. The results given in 
Table XI  have  not  been  corrected for  this  non-specific inactivation but  are 
given as per cent inactivation of the components present in each fraction. 
These  results indicate that  the addition of SK to fractions containing suf- 
ficient plasminogen resulted in the inactivation of the components of C' even 
in  the presence of plasmin inhibitors in serum.  However,  the amount  of SK 584  INACTIVATION  01~  COMPLEMENT  AND  COMPONENTS 
required seemed to depend on the amount of inhibitory activity present. The 
ratio  of plasminogen to  inhibitors determined the  extent of  inactivation by 
SK of the complement components, especially C'I and C'2.  C'4 appeared to 
Tke E 
Final concentration 
of serum 
1:25 
1:50 
1:100 
1:200 
1:400 
1:800 
0 
0 
TABLE  XlI 
~ect of Hydrazine on the Protease Inhibitory Activity of Serum* 
Final concentration 
of plssmin 
unlts  / ml. 
0.75 
0.75 
0.75 
0.75 
0.75 
0.75 
0.75 
0.375 
Untreated serum 
mitt. 
9O 
3O 
13 
9 
9 
9 
Clot lysls time 
Serum treated 
with hydrazlne 
21 
Ii 
ii 
9 
9 
9 
1 
Buffer~ 
mitt, 
9 
14 
* Clot lysis time at 37  ° of a mixture of 0.3 ml. bovine plasmin, 0.3 ml. serum, serially 
diluted with buffer, 0.1 ml. bovine thrombin, and 0.3 ml. bovine fibrinogen. The enzyme and 
serum were incubated at 37  ° for 10 minutes before the aditition of thrombin and fibrinogen. 
I mL of serum was mixed with 0.2 ml. of 0.16 ~s hydrazine (pH 7.8) and incubated at 37  ° for 
1 hour before its protease inhibitory activity was tested. 
:~ Substituted for serum. 
TABLE XIII 
A  Comparison of Effect of Bovine Plasmin, Trypsin, and Streptokinase-Activated Plasmln on 
C' and Its Components 
(A) 1 ml. human serum q- 20 mg.  (16 
units) bovine plasmin. 
(]3)  1 ml. human serum -b 0.6 mg. of 
crystalline trypsin.. 
C)  1 ml. human serum  +  400 units 
SK... 
C' activity 
remaining 
lbsr Gettg 
15 
0 
0 
Component activity remaining 
C:1 
~er cent 
100 
5 
10 
C'2 
per cent 
20 
0 
0 
C~ 
100 
75 
50 
C'4 
p¢r $og 
10 
0 
0 
be most  susceptible to  the  action of  plasminogen either  in the  presence or 
absence of inhibitors. C'3,  except in the absence of inhibitors, was the most 
resistant component to inactivation. 
A  Comparison  of  the  Effect  of Plasmin,  Crystalline  Trypsin,  and  Strepto- 
kinase  on  C'  and Its  Components.--The  experiments  which  have  been  de- L. PILLEMER,  O. D. RATNOFF,  L. BLUM,  AND  I. H. LEPOW  58S 
scribed make it clear that streptokinase destroys C' by activation of plasmino- 
gen to plasmin which  in turn digests  or inactivates the components  of C'. 
Bovine and human preparations of plasmin,  not activated by streptokinase, 
were less effective in destroying C' in whole serum  (Table  XIII). However, 
when these  enzymes  were  added to  R2,  the fraction of serum  insoluble  at 
pH 5.4 and low ionic strength, the remaining  components  of C' were readily 
destroyed  (Table  XIV).  Presumably the  removal of plasmin inhibitors  al- 
lowed the bovine  or human plasmins  to inactivate C'I and C'3,  which were 
partially protected in whole serum. Partially purified CHC13-activated plasmin 
failed to  inactivate complement  in  whole  serum  and  its  activity could  be 
shown only after the removal of serum inhibitors.  It has also been shown that 
CHCla destroys guinea  pig  complement  (27). A  specific inactivation of C'4 
has been claimed by these authors but this was not confirmed here. All the 
TABLE XIV 
Th, Inactivation of C' Components in R2 by Various Plasmins 
1 ml. R2  +  0.5  ml. of 3 times concentrated CHCh-human 
plasmin (partially purified) .......................... 
I ml. R2 +  20rag. bovine  plasmin (16 units) ............. 
1 ml. R2 q- 5 units SK ............................... 
R2  ................................................ 
Activity remaining 
C'I 
~er ce~ 
o 
o 
o 
lOO 
C'3 
per cent 
<5 
0 
<5 
100 
C'4 
i,  ercent 
0 
0 
0 
100 
components  were inactivated by CHCh. The effect of CHCIa on human C' 
was reinvestigated during the course of this study and it was again noted that 
CHCI8 inactivated all four components  of C'. Moreover,  the addition of ade- 
quate amounts of CHCla-treated  serum to C' inactivated all C' components. 
The CHCl3-activated  human plasmin was inactivated at 37  ° in 30 minutes, 
either being unstable under these conditions  or neutralized by serum inhibi- 
tors. 
Crystalline trypsin also destroyed C' in serum  (Table XIII) and appeared 
to behave like SK-activated plasmin. 
DISCUSSION 
Evidence has been  presented that C' is inactivated by plasmin,  the pro- 
teolytic enzyme of plasma or serum active at or near neutral pH. The activa- 
tion of plasminogen,  the precursor  of this enzyme, by streptokinase resulted 
in the inactivation of C' from adult human serum. The components  C'2 and 
C'4 along with varying amounts of C'I and C'3 were destroyed.  C'3 was the 586  INACTIVATION O1  ~  COMPLEMENT  AND  COMPONENTS 
most resistant to inactivation. The addition of streptokinase to infant serum 
proved less  effective in destroying C ~.  Boisvert  (28)  has demonstrated that 
infant serum is  relatively deficient in plasminogen.  Moreover,  the  addition 
of streptokinase  to  monkey, rabbit,  dog,  and  guinea pig  serum  resulted in 
little or no inactivation of C ~. It has been demonstrated by others that these 
species  contain little or no plasminogen susceptible to activation by strepto- 
kinase  (29,  30).  In  contrast,  the  addition  of  streptokinase  to  mixtures  of 
human and monkey serums and to mixtures of human and guinea pig serums 
inactivated not only the C' in human but in the animal serums as well. It was 
observed that the inactivation of human C' by the addition of streptokinase 
was  inhibited  by  high  hydrogen ion  concentrations,  low  temperature,  and 
slight elevations in ionic strength. 
Plasmin which  had been  activated by  chloroform also  inactivated C p in 
systems which did not contain large amounts of plasmin inhibitors. The rela- 
tively  greater  efficiency of  streptokinase-activated  plasmin  has  been  com- 
mented upon earlier  (23,  31).  Studies with fractions of C p showed that the 
degree of inactivation of C ~  and its components by the addition of streptoki- 
nase was dependent on the amount of plasminogen available and on the amount 
of plasmin inhibitor present in the fractions. 
Studies on the nature and function of components of C' (4,  22, 32-35)  and 
the facts presented in this paper  suggest a  possible relationship between C t 
and the plasmin system and common mechanisms in complement "fixation" 
and immune hemolysis. While there is no direct evidence that any component 
of C ~ is identical with any component of the plasmin system, there are supe  r- 
ficial similarities between the properties of C~1 and plasminogen and between 
those of C~2 and C'4 and plasmin inhibitors. A parallelism exists between the 
inactivation of the components of C ~ by plasmin and by antigen-antibody ag- 
gregates (22).  Both systems inactivate C~2 and C~4 and varying amounts of 
C~1 with C~3 being most resistant to destruction. Furthermore, the extent of 
inactivation of each component of C ~  depends upon the quantity of either plas- 
min or  antigen-antibody aggregate present  in  the  mixtures.  Moreover,  the 
inactivation of the components of C t by plasmin or by antigen-antibody ag- 
gregates  (22)  in special  reagents,  R1,  R2,  R3,  and R4,  is almost identical. 
In each case,  the components of R2 were more susceptible to inactivation or 
"fixation" than those of R1. The components in R3 and R4 were inactivated 
or "fixed" in a manner similar to the components in untreated serum. Hydra- 
zine destroys both  C'4 and plasmin inhibitors. The fact that plasmin is  ac- 
tivated by antigen-antibody reactions is also significant (35-38).  The  inhibi- 
tion both of the "fixation" of the components of C t to specific aggregates (22) 
and of the activation of plasmin in slightly hypertonic salt solutions or in high 
hydrogen ion  concentrations is  suggestive  that  similar mechanisms are  in- 
volved. These results suggest that the plasmin system may be  involved  in L. PILLEMER,  O. D. KATNOFF, L. BLUM, AND  I. H. LEPOW  587 
complement  "fixation" and  in  immune  hemolysis. The  discovery that  the 
components of C' are inactivated by plasmin may also help to elucidate  the 
roles of these agents in allergic states. Work is under way here to  determine 
the exact rote of the enzyme and its associated factors in immune phenomena. 
The  "spontaneous" inactivation of  C'  and  the  marked  instability of  C t 
and its components on standing have long been laboratory problems. Serum, on 
standing, decreaaes in C' titer, or becomes anticomplementary, or both. Bac- 
terial  contamination  or  the  addition  of  various  bacteriostatic  agents,  es- 
pecially organic solvents, causes a sharp fall in C r titer with the development 
of anticomplementary properties in the serum. It is likely that part or all of 
such inactivation of C' and the acquisition of anticomplementary properties 
are due to "spontaneous" activation of plasmin or to activation of this enzyme 
by bacterial products or other agents. Work is in progress here to find suitable 
plasmin inhibitors which are not anticomplementary per se and do not inter- 
fere in immune hemolysis, but which will stabilize C'. On the basis of the fore- 
going work, a revision of present concepts of the nature and mode of action of 
many anticomplementary agents may be necessary. 
Purification of the components of C' has been handicapped by instability 
during fractionation procedures.  Cq,  C'3, and C~4 are separated initially by 
conditions which also precipitate plasminogen (32,  33).  It was noted during 
purification of human C'I  that C'3 and C~4 disappeared spontaneously and 
such samples often exhibited anticomplementary properties  (32,  33).  It has 
since been noticed here that Cq titers also decrease. The rate of this inactiva- 
tion can be increased greatly by the addition of minute amounts of strepto- 
kinase to the purified samples (Table X) or by increasing the alkalinity of the 
samples to pH 7.0 or greater. Such observations can now be explained on the 
basis that the activ~ion of plasmin in these fractions results in the inactiva- 
tion of the C' components. Attempts are being made to separate plasminogen 
from C'I, C'3, and C~4, and to investigate the possibility of finding specific 
inhibitors for plasmin or for the conversion of plasminogen to plasmin. The 
actual isolation of native components of C p will necessarily await the outcome 
of such studies. 
Finally, the inactivation of the components of C' by plasmin may serve as 
a  method for  the  estimation of plasminogen, plasmin,  and  their activators 
and inhibitors. The test is very sensitive, especially when R2 is the substrate. 
One objection to this method is that substrate, precursor, enzyme, and other 
factors are present simultaneously. However, experiments are in progress  to 
attempt to overcome this objection. 
SUMMARY 
Human complement is inactivated by plasmin, the proteolytic enzyme of 
plasma or serum active at or near neutrality. 588  INACTIVATION O1  e  COMPLEMENT  AND  COMPONENTS 
The addition of streptokinase to human serum, which converts plasminogen 
to plasmin, also causes the inactivation of complement components C'2 and 
Ct4 and varying amounts of C'1. C'3 is the most resistant to inactivation by 
plasmin. Chloroform-activated human plasmin and bovine plasmin also destroy 
these  components  of  complement,  but  are  less  effective than  the  strepto- 
kinase-activated enzyme. The inactivation of complement by the addition of 
streptokinase to human serum is inhibited by high hydrogen ion concentra- 
tions, low temperature, and elevated ionic strength. The inactivation of the 
components of complement in various fractions of serum is influenced by the 
available plasminogen and  the  content of plasmin  inhibitors in  these  frac- 
tions. 
Certain  similarities are  pointed out between  the  components of  comple- 
ment and the factors in the plasmin system and between the inactivation of 
the  components  of  complement by  antigen-antibody reactions,  by  specific 
agents, and by plasmin. 
The possible significance of these relationships in immune hemolysis and 
complement fixation, and the possible role of the plasmin system in the in- 
stability of complement and the development of anticomplementary properties 
in serum are discussed. 
Thanks are due to Miss Joan Colopy  and Mr. Jack Pensky for their technical assistance. 
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